Back

The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in Idiopathic Pulmonary Fibrosis

Karampitsakos, T.; Tourki, B.; Jia, M.; Perrot, C. Y.; Visinescu, B.; Zhao, A.; Unterman, A.; Tzouvelekis, A.; Bandyopadhyay, D.; Juan-Guardela, B. M.; Prasse, A.; Noth, I.; Liggett, S.; Kaminski, N.; Benos, P. V.; Herazo-Maya, J. D.

2024-08-08 respiratory medicine
10.1101/2024.08.07.24311386 medRxiv
Show abstract

RationaleThe association between immune-cell-specific transcriptomic profiles and Idiopathic Pulmonary Fibrosis (IPF) mortality is unknown. ObjectivesTo determine immune-cell-specific transcriptomic profiles associated with IPF mortality. MethodsWe profiled peripheral blood mononuclear cells (PBMC) in 18 participants [University of South Florida: IPF, COVID-19, post-COVID-19 Interstitial Lung Disease (Post-COVID-19 ILD), controls] by single-cell RNA sequencing (scRNA-seq) and identified 16 immune-cell-specific transcriptomic profiles. The Scoring Algorithm of Molecular Subphenotypes (SAMS) was used to calculate Up-scores based on these 16 gene profiles. Their association with outcomes was investigated in peripheral blood, Bronchoalveolar Lavage (BAL) and lung tissue of N=416 IPF patients from six cohorts. Findings were validated in an independent IPF, PBMC scRNA-seq dataset (N=38). Measurements and main resultsCox-regression models demonstrated that 230 genes from CD14+CD163-HLA-DRlow circulating monocytes predicted IPF mortality [Pittsburgh (p=0.02), Chicago (p=0.003)]. PBMC proportions of CD14+CD163-HLA-DRlow monocytes were higher in progressive versus stable IPF (Yale, 0.13{+/-}0.05 versus 0.09{+/-}0.05, p=0.034). Receiving operating characteristic identified a 230 gene, Up-score >41.84 (Pittsburgh) predictive of mortality in Chicago (HR: 6.58, 95%CI: 2.15-20.13, p=0.001) and in pooled analysis of BAL cohorts (HR: 2.20, 95%CI: 1.44-3.37, p=0.0003). High-risk patients had decreased expression of the T-cell co-stimulatory genes CD28, ICOS, ITK and LCK (Pittsburgh and Chicago, p<0.01). 230 gene-up-scores negatively correlated with Forced Vital Capacity (FVC) in IPF lung tissues (LGRC, rho=-0.2, p=0.02). Results were replicated using a subset of 13 genes from the 230-gene signature (pooled PBMC cohorts - HR: 5.34, 95%CI: 2.83-10.06, p<0.0001). ConclusionsThe transcriptome of CD14+CD163-HLA-DRlow monocytes is associated with increased IPF mortality.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.1%
37.8%
2
European Respiratory Journal
54 papers in training set
Top 0.1%
22.6%
50% of probability mass above
3
Thorax
32 papers in training set
Top 0.2%
4.3%
4
ERJ Open Research
44 papers in training set
Top 0.2%
4.0%
5
BMJ Open Respiratory Research
32 papers in training set
Top 0.2%
3.6%
6
Respiratory Research
19 papers in training set
Top 0.1%
3.6%
7
Frontiers in Immunology
586 papers in training set
Top 3%
2.4%
8
Leukemia
39 papers in training set
Top 0.4%
2.1%
9
JCI Insight
241 papers in training set
Top 3%
1.9%
10
Journal of Internal Medicine
12 papers in training set
Top 0.3%
1.3%
11
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.6%
1.1%
12
Scientific Reports
3102 papers in training set
Top 68%
1.1%
13
Clinical Immunology
21 papers in training set
Top 0.4%
1.0%
14
Arthritis & Rheumatology
33 papers in training set
Top 0.4%
0.9%
15
The American Journal of Pathology
31 papers in training set
Top 0.4%
0.9%
16
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.7%
17
Nature Communications
4913 papers in training set
Top 64%
0.7%
18
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
19
Biomedicines
66 papers in training set
Top 4%
0.6%
20
Journal of Clinical Pathology
12 papers in training set
Top 0.6%
0.6%
21
eBioMedicine
130 papers in training set
Top 5%
0.6%
22
Metabolites
50 papers in training set
Top 1%
0.6%